The observed downregulation of cIAP2, a G2/M phase cell cycle regulator [54–55], after treatment with Artonin E, had also been suspected as a contributing factor to the accumulation of MDA-MB 231 breast cancer cells in the G2/M phase [56]. The gene discussed is BIRC3; the disease is breast cancer.